Matthew James Leoni
CIK: 0002150640
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KRSA
Korsana Biosciences, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Leoni Matthew James
Leoni Matthew James (SEC CIK 0002150640) files insider reports with the SEC as Chief Medical Officer of Korsana Biosciences, Inc. (KRSA).
Signal8 holds 1 ownership filing by Leoni Matthew James, a Form 3, filed on Sep 10, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Leoni Matthew James's filings is in WALTHAM, MA.
Other insiders filing for Korsana Biosciences, Inc. (KRSA)
- Pernice Michelle Patricia, Director
- Shah Nimish P, Director
- Fairmount Funds Management LLC, Director
- Gottesdiener Andrew, Director
- Violin Jonathan
- HENSON HEIDI, Director